NEO
NeoGenomics Inc
19.30$
-1.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 53.2% | 56.2% | 54.8% | 57.6% | 54.0% | 51.9% | 58.2% | 61.4% | 63.1% | 58.7% | 56.1% | 61.2% | |
| 46.8% | 43.8% | 45.2% | 42.4% | 46.0% | 48.1% | 41.8% | 38.6% | 36.9% | 41.3% | 43.9% | 38.8% | |
| 3.1% | 4.2% | 1.9% | 1.5% | 1.1% | 2.1% | 1.9% | 4.5% | 5.9% | 4.6% | 4.7% | 5.1% | |
| 27.3% | 33.7% | 26.2% | 36.9% | 30.7% | 31.3% | 32.4% | 45.7% | 41.3% | 35.3% | 34.2% | 37.6% | |
| 44.2% | 49.5% | 39.3% | 41.2% | 42.4% | 45.0% | 45.0% | 63.1% | 67.8% | 59.6% | 57.9% | 47.9% | |
| 2.5% | -5.6% | 1.1% | 1.2% | 3.6% | 3.2% | -3.1% | -24.5% | -30.9% | -18.2% | -13.9% | -9.1% | |
| 1.1% | 0.9% | 4.1% | 2.3% | 2.3% | 0.9% | 1.6% | 1.7% | 1.5% | 1.2% | 1.0% | 0.5% | |
| 1.5% | -4.5% | -3.0% | -1.1% | 1.4% | 0.9% | -3.2% | -3.1% | -31.3% | -16.4% | -12.2% | -15.2% | |
| 0.2% | -2.0% | -0.7% | -0.9% | 0.4% | -1.1% | -4.1% | -1.4% | -3.0% | -1.5% | -0.3% | -0.3% | |
| 1.3% | -2.5% | -2.5% | -0.2% | 1.0% | 2.0% | 0.9% | -1.7% | -28.3% | -14.9% | -11.9% | -14.9% | |
| 9.0% | 3.5% | 10.4% | 11.1% | 11.5% | 9.2% | 7.8% | 9.6% | -16.2% | -3.0% | -0.2% | -5.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.